Every year on May 8, the world observes World Ovarian Cancer Day to spread awareness about ovarian cancer, the second most ...

CK Wang, MD, chief medical officer of COTA, highlights how a lack of screening tools and declining ob-gyn pipeline can compound historical disparities seen in Black women's access to care.

Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection. Increased awareness of symptoms like persistent bloating and pelvic ...

Ovarian cysts, which are small fluid-filled sacs that develop in or on the ovaries, are very common and are usually harmless.

Most ovarian cancers are diagnosed at later stages due to this lack of clear early warning signs,” says Dr Yogesh Kulkarni, ...

The KEYNOTE-B96 study of pembrolizumab plus paclitaxel in recurrent platinum-resistant ovarian cancer has met its primary end ...

High-risk advanced ovarian cancer patients showed marginal survival benefit with bevacizumab added to first-line chemotherapy. Patients without high-risk characteristics did not show significant ...

The new National Cancer Plan offers a real chance to close survival gaps by making early diagnosis and fair access to ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Avutometinib given with defactinib is now approved for the treatment of adult patients with recurrent low-grade serous, ...